Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSTAMATINIB for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 5 adverse event reports in the FDA FAERS database where FOSTAMATINIB was used for Prostate cancer.

Most Reported Side Effects for FOSTAMATINIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 904 14.1% 19 97
Platelet count decreased 804 12.6% 8 312
Product dose omission issue 711 11.1% 1 128
Off label use 680 10.6% 42 151
Hospitalisation 403 6.3% 24 403
Platelet count 375 5.9% 5 73
Drug ineffective 340 5.3% 4 44
Fatigue 332 5.2% 5 43
Blood pressure increased 314 4.9% 1 29
Death 307 4.8% 306 33
Headache 237 3.7% 6 25
Hypertension 213 3.3% 12 45
Product prescribing issue 206 3.2% 11 45
Nausea 197 3.1% 2 29
Dizziness 193 3.0% 0 31

Other Indications for FOSTAMATINIB

Immune thrombocytopenia (4,438) Immune thrombocytopenic purpura (501) Thrombocytopenia (483) Product used for unknown indication (407) Autoimmune haemolytic anaemia (59) Iron deficiency anaemia (22) Myelodysplastic syndrome (19) Chronic lymphocytic leukaemia (18) Haemolytic anaemia (18) Anaemia (16)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

FOSTAMATINIB Full Profile All Prostate cancer Drugs FOSTAMATINIB Demographics FOSTAMATINIB Timeline